Athersys CEO to Speak at the 2018 Brain Health Summit
January 29, 2018 06:00 ET
|
Athersys, Inc.
CLEVELAND, Ohio, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van Bokkelen, Chairman and CEO, will be a speaker and panelist at the 2018 Brain Health...
HEALIOS Announces Enrollment of First Patient in Japan in TREASURE Study of MultiStem® Treatment for Ischemic Stroke
November 15, 2017 10:05 ET
|
Athersys, Inc.
CLEVELAND, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that its partner, HEALIOS K.K. (“Healios”), has enrolled the first patient in its study in Japan evaluating...
Athersys Reports Third Quarter 2017 Results
November 08, 2017 16:03 ET
|
Athersys, Inc.
CLEVELAND, Nov. 08, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the three months ended September 30, 2017. Highlights of the third quarter of...
Athersys and Nikon CeLL Innovation to Collaborate on MultiStem® Commercial Manufacturing in Japan
October 11, 2017 06:00 ET
|
Athersys, Inc.
CLEVELAND, Oct. 11, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced that it has entered into a manufacturing services agreement with Nikon CeLL innovation Co., Ltd. (NCLi) for...
Athersys to Host Third Quarter Financial Results Call
October 09, 2017 10:00 ET
|
Athersys, Inc.
CLEVELAND, Oct. 09, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its third quarter 2017 financial results at approximately 4:00 PM Eastern Time on Wednesday, November 8, 2017,...
Athersys to Present at 2017 Cell & Gene Meeting on the Mesa and Announces Regenerative Medicine Advanced Therapy (RMAT) Designation From FDA
October 05, 2017 07:00 ET
|
Athersys, Inc.
CLEVELAND, Oct. 05, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that Robert W. Mays, Ph.D., Vice President, Regenerative Medicine and Head of Neuroscience Programs, will...
Athersys Reports Second Quarter 2017 Results
August 09, 2017 16:05 ET
|
Athersys, Inc.
CLEVELAND, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the three months ended June 30, 2017. Highlights of the second quarter of 2017...
Athersys Reports Alignment of Key Regulators for Pivotal Registration Study in Stroke
August 07, 2017 06:00 ET
|
Athersys, Inc.
MultiStem® stem cell technology receives Positive Opinion from European Medicines Agency Adds to Special Protocol Assessment and Fast Track designation in U.S., and Priority Review under Sakigake...
Athersys to Host Second Quarter Financial Results Call
July 10, 2017 10:00 ET
|
Athersys, Inc.
CLEVELAND, July 10, 2017 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) will release its second quarter 2017 financial results at approximately 4:00 PM Eastern Time on Wednesday, August 9, 2017,...
Athersys Reports First Quarter 2017 Results
May 09, 2017 16:05 ET
|
Athersys, Inc.
Company announces Fast Track Designation by FDA for Stroke Program and other progress Management to host conference call at 4:30pm EDT todayCLEVELAND, May 09, 2017 (GLOBE NEWSWIRE) --...